Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-FR Version v23-EN
Language French English
Date Updated 2023-08-17 2023-08-17
Drug Identification Number 02421526 02421526
Brand name TARO-MEROPENEM TARO-MEROPENEM
Common or Proper name MEROPENEM MEROPENEM
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients MEROPENEM MEROPENEM
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10X1V 10X1V
ATC code J01DH J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-01 2022-05-01
Estimated end date 2023-07-28 2023-07-28
Actual end date 2023-07-25 2023-07-25
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments